A detailed history of Bdf Gestion transactions in Eli Lilly & CO stock. As of the latest transaction made, Bdf Gestion holds 30,196 shares of LLY stock, worth $23.2 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
30,196
Previous 30,196 -0.0%
Holding current value
$23.2 Million
Previous $27.3 Billion 78.6%
% of portfolio
0.63%
Previous 2.63%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$724.87 - $909.04 $21.9 Million - $27.4 Million
30,196 New
30,196 $27.3 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bdf Gestion Portfolio

Follow Bdf Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdf Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Bdf Gestion with notifications on news.